| Literature DB >> 27838554 |
Naisarg Pujara1, Siddharth Jambhrunkar1, Kuan Yau Wong2, Michael McGuckin2, Amirali Popat3.
Abstract
The polyphenolic compound resveratrol has received significant attention due to its many pharmacological actions such as anti-cancer, anti-inflammatory, antioxidant and antimicrobial activities. However, poor solubility and stability are major impediments for resveratrol's clinical effectiveness. In this work we have encapsulated resveratrol into soy protein isolate nanoparticles using a simple rotary evaporation technique. Resveratrol-loaded nanoparticles were around 100nm in diameter and negatively charged. Nano-encapsulated resveratrol was found to be in amorphous form and showed more than two times higher solubility with significantly increased dissolution when compared to free resveratrol. Finally, an in-vitro NF-κB inhibition assay revealed that encapsulated resveratrol was stable and retained bioactivity. This new formulation of resveratrol has the potential to boost the clinical effectiveness of this drug and could be utilised for other poorly soluble hydrophobic drugs. Copyright ÂEntities:
Keywords: Colloidal stability; Control release; Nanocomplex; Resveratrol; Solubility; Soy protein isolate
Mesh:
Substances:
Year: 2016 PMID: 27838554 DOI: 10.1016/j.jcis.2016.11.015
Source DB: PubMed Journal: J Colloid Interface Sci ISSN: 0021-9797 Impact factor: 8.128